Tuesday’s Biggest Winners and Losers in the S&P 500
Tuesday was a positive day for the broad U.S. markets with the S&P 500 within points of its all-time high. Crude oil made a solid recovery the session as well. The S&P 500 sectors…
All Work
Chris Lange
What to Watch For in Micron’s Earnings Report on Thursday
Micron is scheduled to release its most recent quarterly results late on Thursday and analysts are looking for solid growth on the top and bottom lines.
Does AutoZone Deserve More From Its Q4 Report?
AutoZone shares slipped after the specialty retailer released a mixed quarterly report early on Tuesday.
Why Tilray Shares Are Getting Even Higher
Tilray continued its incredible rally with shares up massively on Tuesday after the U.S. Drug Enforcement Administration granted approval for the company to import a cannabinoid study drug for a clinical trial at the…
Meet the New Macy’s Facebook Collaboration: Just in Time for the Holidays
Macy’s announced that it would be partnering with Facebook in an effort to expand its e-commerce customer experience. The retail chain will also be adding other new features to its enterprise including virtual reality…
Why Viking Therapeutics Fatty Liver Study More Than Doubled Shares
Viking Therapeutics shares more than doubled on Tuesday after the company announced results from its mid-stage non-alcoholic fatty liver disease trial.
Why FedEx Failed to Deliver in Q1
FedEx shares slipped after it reported mixed fiscal first-quarter financial results after the markets closed on Monday.
Why Oracle Is Monday’s Big Earnings Loser
Oracle released mixed fiscal first-quarter financial results after the markets closed on Monday.
Monday’s Biggest Winners and Losers in the S&P 500
Monday was a down day for the broad U.S. markets with the Nasdaq especially taking it on the chin. Crude oil pulled back in the session as well. The S&P 500 sectors were more…
CRISPR Therapeutics Partners Up to Take on Diabetes
CRISPR Therapeutics shares dipped on Monday after the company announced a collaboration with ViaCyte focused on the discovery, development and commercialization of gene-edited allogeneic stem cell therapies for the treatment of diabetes.
What to Watch For in FedEx’s Q1 Report
FedEx is set to release its quarterly results after the markets close on Monday and analysts are looking for strong year-over-year growth.
How Amazon Is Breaking Into Small Business
Amazon shares dipped on Monday after it was announced that the e-commerce empire was opening a new store for customers to shop exclusively from U.S. small and medium-sized businesses selling on Amazon.
What to Expect When Oracle Reports After the Close
Oracle is scheduled to release its most recent quarterly results after the markets close on Monday.
How Starbucks Is Saving Some Green With Its New Store Initiative
Starbucks is planning to open 10,000 new "greener stores" by 2025 as part of its green initiative. The coffee giant announced earlier this summer that it was doing away with plastic straws.
Urovant Closes in on IPO
Clinical-stage biopharmaceutical company Urovant Sciences intends to price 10 million shares for an initial public offering valued up to $184 million.
How Teva Won FDA Approval for Ajovy
Teva Pharmaceuticals shares made a solid gain on Monday morning after the company announced a critical approval by the FDA.
Oracle, Micron, FedEx and More Major Earnings Coming This Week
24/7 Wall St. has put together a preview of Oracle, Micron, FedEx and some of the other companies that are about to report their quarterly results.
Did Constellation Overpay for Its Marijuana Experiment?
While it seems Constellation Brands made a solid move into the “cannabis space,” analysts don’t think as highly of the deal.
What Analysts Are Saying After Adobe’s Record Report
Adobe Systems shares reached an all-time high in Friday’s session following a record earnings report. Overall everything seemed to go right in this report with revenues hitting a record level.
Friday’s Biggest Winners and Losers in the S&P 500
Friday was a flat day for the broad U.S. markets. Crude oil made a small recovery back towards $70. The S&P 500 sectors were mostly negative.